Richard J. Poulton - 15 Nov 2022 Form 4 Insider Report for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX)

Role
CEO, Director
Signature
Holly Teague by power of attorney for Richard Poulton
Issuer symbol
MDRX
Transactions as of
15 Nov 2022
Net transactions value
-$362,018
Form type
4
Filing time
16 Nov 2022, 16:34:17 UTC
Previous filing
16 Aug 2022
Next filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDRX Common Stock Sale $181,388 -10,000 -1.4% $18.14 722,517 15 Nov 2022 Direct F1, F2
transaction MDRX Common Stock Gift $0 -23,500 -3.3% $0.000000 699,017 15 Nov 2022 Direct
transaction MDRX Common Stock Sale $180,630 -10,000 -1.4% $18.06 689,017 16 Nov 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares reported in the Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
F2 These transactions were executed in multiple trades at prices ranging from $17.90 to $18.36. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected.
F3 These transactions were executed in multiple trades at prices ranging from $17.62 to $18.17. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected.